Clinical trial
Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI
NCT02640586 is registered in ClinicalTrials.gov with Sun Ying-Shi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI
- Lead sponsor
- Sun Ying-Shi
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 10, 2016
- Completion date
- December 31, 2023
- Enrollment
- 1,614 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.